Your shopping cart is currently empty

iFSP1, a potent, selective, and glutathione-independent ferroptosis suppressor protein 1 (FSP1) (AIFM2) inhibitor with an EC50 of 103 nM, sensitizes diverse human cancer cell lines to ferroptosis inducers like (1S,3R)-RSL3. It uniquely triggers ferroptosis in GPX4-knockout cells overexpressing FSP1.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $29 | In Stock | In Stock | |
| 10 mg | $42 | In Stock | In Stock | |
| 25 mg | $95 | In Stock | In Stock | |
| 50 mg | $175 | In Stock | In Stock | |
| 100 mg | $328 | - | In Stock |
| Description | iFSP1, a potent, selective, and glutathione-independent ferroptosis suppressor protein 1 (FSP1) (AIFM2) inhibitor with an EC50 of 103 nM, sensitizes diverse human cancer cell lines to ferroptosis inducers like (1S,3R)-RSL3. It uniquely triggers ferroptosis in GPX4-knockout cells overexpressing FSP1. |
| Targets&IC50 | FSP1:103 nM (EC50) |
| In vitro | iFSP1 (0.001-1 μM; 24 hours) is less effective than genetic deletion of FSP1, and its treatment in the FSP1-knockout background does not enhance RSL3-induced ferroptosis. iFSP1 (3 μM; 24 hours) causes significant toxicity of RSL3 in a panel of genetically engineered (FSP1-knockout) human cancer cell lines. AIFM2, now renamed ferroptosis suppressor protein 1 (FSP1), is identified as a previously unrecognized anti-ferroptotic gene. iFSP1 (0.001-1 μM; 24 hours) inhibits the growth of Gpx4-knockout cells in a dose-dependent manner but does not affect wild type cells. Treatment with the ferroptosis inhibitor Lip-1 protects GPX4-knockout cells from iFSP1-induced ferroptosis. |
| Molecular Weight | 323.35 |
| Formula | C20H13N5 |
| Cas No. | 150651-39-1 |
| Smiles | Cc1ccc(cc1)-c1c(C#N)c(N)n2c3ccccc3nc2c1C#N |
| Relative Density. | 1.31 g/cm3 (Predicted) |
| Storage | The compound is unstable in solution. Please use soon | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 25 mg/mL (77.32 mM), Sonication is recommended.The compound is unstable in solution, please use soon. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.